Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirer

Emcure Pharmaceuticals witnessed a block deal on Wednesday in which a Mauritius-based investment entity BC Investments IV Limited sold 18 lakh shares in a transaction that was valued at Rs 289 crore.

The shares were purchased by Norges Bank on Account of The Government Pension Fund Global at a price of Rs 1,608.2 apiece. The stock today ended with strong gains of 8% at Rs 1,729.90 on the NSE.

BC Investments IV, an affiliate of Bain Capital, held over 73.39 lakh shares accounting for 3.87% stake in the company as on March 31, 2026.


The stock has delivered returns of 67% in the past 12 months, outperforming the benchmarks Nifty and the BSE Sensex, whose returns in the same period stand at -1% and -3%, respectively.

The stock is currently trading above its 50-day and 200-day simple moving averages (SMAs) of Rs 1,535 and Rs 1,438, respectively, according to Trendlyne data.

The pharma company is into manufacturing APIs and formulations.

The company reported a consolidated net profit of Rs 231 crore which is a growth of 50% over Rs 154 crore reported in the year ago period. The company reported a total revenue of Rs 2,365 crore which is growth of 20% YoY versus Rs 1,966 crore in the corresponding quarter of the last financial year.

Emcure Pharmaceuticals is a smallcap stock with a market capitalization of Rs 32,742 crore.

Also read: Delhivery block deals worth Rs 186 crore see Goldman Sachs, Morgan Stanley, MFs step in; Nexus sells stake

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)